Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung...
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
About this item
Full title
Author / Creator
Kim, Nayoung , Park, Sehhoon , Jo, Areum , Eum, Hye Hyeon , Kim, Hong Kwan , Lee, Kyungjong , Cho, Jong Ho , Ku, Bo Mi , Jung, Hyun Ae , Sun, Jong-Mu , Lee, Se-Hoon , Ahn, Jin Seok , Lee, Jung-Il , Choi, Jung Won , Jeong, Dasom , Kang, Huiram , Kim, Jeong Yeon , Choi, Jung Kyoon , Lee, Hae-Ock and Ahn, Myung-Ju
Publisher
England: eLife Sciences Publications Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: eLife Sciences Publications Ltd
Subjects
More information
Scope and Contents
Contents
This study investigates the variability among patients with non-small cell lung cancer (NSCLC) in their responses to immune checkpoint inhibitors (ICIs). Recognizing that patients with advanced-stage NSCLC rarely qualify for surgical interventions, it becomes crucial to identify biomarkers that influence responses to ICI therapy. We conducted an an...
Alternative Titles
Full title
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a6cc1516727f4f3688947a807a310c49
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a6cc1516727f4f3688947a807a310c49
Other Identifiers
ISSN
2050-084X
E-ISSN
2050-084X
DOI
10.7554/eLife.98366
